Valneva Says FDA Has Delayed Chikungunya Vaccine Review Date

By Maitane Sardon

Valneva said Monday that the U.S. Food and Drug Administration has delayed the target date for completing the regulatory review of the marketing application for its chikungunya vaccine candidate to the end of November, from end of August previously.

The French biotech company said the FDA extended the date to allow sufficient…